Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant

NCT00288028 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

15

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

DRUG: bortezomib

Sponsor

Barbara Ann Karmanos Cancer Institute

Collaborators

[object Object]